Correlation Between Enlivex Therapeutics and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Lumos Pharma, you can compare the effects of market volatilities on Enlivex Therapeutics and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Lumos Pharma.
Diversification Opportunities for Enlivex Therapeutics and Lumos Pharma
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enlivex and Lumos is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Lumos Pharma go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Lumos Pharma
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Lumos Pharma. In addition to that, Enlivex Therapeutics is 1.47 times more volatile than Lumos Pharma. It trades about -0.01 of its total potential returns per unit of risk. Lumos Pharma is currently generating about 0.05 per unit of volatility. If you would invest 301.00 in Lumos Pharma on August 24, 2024 and sell it today you would earn a total of 132.00 from holding Lumos Pharma or generate 43.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Lumos Pharma
Performance |
| Timeline |
| Enlivex Therapeutics |
| Lumos Pharma |
Enlivex Therapeutics and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Lumos Pharma
The main advantage of trading using opposite Enlivex Therapeutics and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |